Physician profile
Allyson Jones
NPI 1508852567
$764.62
in general payments reported to CMS, 2019-2025
18 companies · $206 in 2025
The $206 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.70 · 2020: $25.21 · 2022: $121 · 2023: $285 · 2024: $61.36 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $552.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $213.69 | 2023 | Enseal |
| Abbvie INC. | $173.01 | 2019-2025 | |
| Astellas Pharma US INC | $59.68 | 2025 | Veozah |
| Minerva Surgical, INC | $46.59 | 2022 | |
| Coopersurgical, INC. | $44.49 | 2024 | Advincula Delineator Uterine Manipulator |
| Mayne Pharma Commercial LLC | $23.85 | 2025 | |
| Sage Therapeutics, LLC | $21.38 | 2025 | Zurzuvae |
| Ethicon US, LLC | $21.04 | 2023 | Ethicon |
| Agile Therapeutics, INC. | $19.40 | 2022 | |
| Sumitomo Pharma America, INC. | $17.26 | 2023 | Myfembree |
| Gynesonics, INC. | $16.87 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Applied Medical Resources Corporation | $16.82 | 2023 | |
| Meditrina | $16.36 | 2025 | |
| Hologic Sales and Service, LLC | $16.30 | 2025 | Myosure Tissue Removal Device |
| Pfizer INC. | $16.17 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $16.07 | 2025 | Slynd |
| Duchesnay USA Incorporated | $13.38 | 2019 | |
| Avion Pharmaceuticals | $12.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allyson Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.